114 related articles for article (PubMed ID: 10550524)
1. After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour.
Granfors T; Tomic R; Bergh A; Rydh M; Löfroth PO; Widmark A
Urol Res; 1999 Oct; 27(5):357-61. PubMed ID: 10550524
[TBL] [Abstract][Full Text] [Related]
2. Fractionated radiotherapy of rat prostatic adenocarcinoma (Dunning R3327-PAP) in nonanesthetized animals.
Granfors T; Bergh A; Löfroth PO; Widmark A
Prostate; 1999 Apr; 39(1):16-22. PubMed ID: 10221261
[TBL] [Abstract][Full Text] [Related]
3. Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma.
Granfors T; Damber JE; Bergh A; Landström M; Löfroth PO; Widmark A
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1031-6. PubMed ID: 9392541
[TBL] [Abstract][Full Text] [Related]
4. Estrogen treatment postpones the castration-induced dedifferentiation of Dunning R3327-PAP prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A
Prostate; 1994 Jul; 25(1):10-8. PubMed ID: 8022707
[TBL] [Abstract][Full Text] [Related]
5. Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluation.
Kager M; Spruss T; Schneider MR; von Angerer E
J Cancer Res Clin Oncol; 1992; 118(5):334-8. PubMed ID: 1583064
[TBL] [Abstract][Full Text] [Related]
6. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
7. Blood flow in the Dunning R3327H rat prostatic adenocarcinoma; effects of oestradiol and testosterone.
Daehlin L; Damber JE
Urol Res; 1986; 14(2):113-7. PubMed ID: 3727214
[TBL] [Abstract][Full Text] [Related]
8. Alterations of tumour cells, stroma and apoptosis in rat prostatic adenocarcinoma following treatment with histamine, interleukin-2 and irradiation.
Johansson S; Landström M; Henriksson R
Anticancer Res; 1999; 19(3A):1961-9. PubMed ID: 10470141
[TBL] [Abstract][Full Text] [Related]
9. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
Sylvester PW; Ip MM
Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
[TBL] [Abstract][Full Text] [Related]
10. The response of Dunning R3327 prostatic adenocarcinoma to IL-2, histamine and radiation.
Johansson S; Landström M; Hellstrand K; Henriksson R
Br J Cancer; 1998 Apr; 77(8):1213-9. PubMed ID: 9579825
[TBL] [Abstract][Full Text] [Related]
11. Effects of 6-methylene progesterone on growth, morphology, and blood flow of the Dunning R3327 prostatic adenocarcinoma.
Damber JE; Bergh A; Daehlin L; Petrow V; Landström M
Prostate; 1992; 20(3):187-97. PubMed ID: 1574466
[TBL] [Abstract][Full Text] [Related]
12. Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A; Tomic R
J Cancer Res Clin Oncol; 1992; 118(1):30-4. PubMed ID: 1729258
[TBL] [Abstract][Full Text] [Related]
13. Coordinate loss of growth regulatory factors following castration of rats carrying the Dunning R3327 G prostatic tumor.
Rubenstein M; Shaw M; Targonski P; McKiel CF; Dubin A; Guinan PD
Clin Physiol Biochem; 1992; 9(2):47-50. PubMed ID: 1284786
[TBL] [Abstract][Full Text] [Related]
14. Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma.
Westin P; Brändström A; Damber JE; Bergh A
Br J Cancer; 1995 Jul; 72(1):140-5. PubMed ID: 7599043
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A; Tomic R; Carlsson-Bostedt L; Stigbrand T
Prostate; 1988; 12(4):287-98. PubMed ID: 3393491
[TBL] [Abstract][Full Text] [Related]
16. Effect of active immunization against luteinizing hormone-releasing hormone on the androgen-sensitive Dunning R3327-PAP and androgen-independent Dunning R3327-AT2.1 prostate cancer sublines.
Fuerst J; Fiebiger E; Jungwirth A; Mack D; Talwar PG; Frick J; Rovan E
Prostate; 1997 Jul; 32(2):77-84. PubMed ID: 9215394
[TBL] [Abstract][Full Text] [Related]
17. The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions.
Pollack A; Ashoori F; Sikes C; Joon DL; von Eschenbach AC; Zagars GK; Meistrich ML
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):153-8. PubMed ID: 10656387
[TBL] [Abstract][Full Text] [Related]
18. Alterations of physical and biochemical parameters of the R3327-CP rat prostate adenocarcinoma following hormonal manipulation of the host.
Buttyan R; Tomashefsky P; Deitch AD; Olsson CA; Devere-White R
J Urol; 1984 Jun; 131(6):1218-24. PubMed ID: 6726931
[TBL] [Abstract][Full Text] [Related]
19. Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated Dunning R3327 prostatic adenocarcinoma.
Westin P; Bergh A; Damber JE
Prostate; 1993; 22(1):65-74. PubMed ID: 8426839
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral effects of R 75251 on the growth of transplantable R3327 prostatic adenocarcinoma in rats.
Van Ginckel R; De Coster R; Wouters W; Vanherck W; van der Veer R; Goeminne N; Jagers E; Van Cauteren H; Wouters L; Distelmans W
Prostate; 1990; 16(4):313-23. PubMed ID: 2371176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
